Biofrontera (BFRI) Income Statement: Revenue & Earnings

Biofrontera Income Statement Analysis

Revenue, earnings, and profit margins in millions USD

Scale:

Scroll to see more

Biofrontera Inc. income statement - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Revenue & Gross Profit
Revenue	37.32	34.07	28.67	24.10	18.85
Cost of Revenue	18.61	17.44	15.19	12.74	9.07
Gross Profit	18.71	16.63	13.49	11.36	9.78
Operating Expenses
Research & Development	2.09	0.08	0.00	0.00	0.00
Selling, General & Administrative	33.84	39.13	35.87	25.96	18.12
Operating Expenses	35.92	39.20	35.87	25.96	18.12
Operating Income	-17.21	-22.58	-22.38	-14.60	-8.33
Other Income/Expense
Interest Income	0.07	0.13	0.18	0.02	0.03
Interest Expense	-2.11	0.60	0.37	-0.36	-2.90
Other Income/Expense	1.64	3.02	21.98	-12.65	0.08
Income
Income Before Tax	-17.74	-20.12	-0.61	-37.66	-10.92
Income Tax Expense	0.02	0.01	0.03	0.06	0.06
Net Income	-17.76	-20.13	-0.64	-37.71	-10.99
Net Income - Continuous Operations	-17.76	-20.13	-0.64	-37.71	0.00
Net Income - Discontinued Operations	0.00	0.00	0.00	0.00	0.00
EBITDA	-16.79	-18.45	0.93	-14.06	-7.77
EBIT	-17.21	-19.52	-0.24	-14.60	-8.33
Depreciation & Amortization	0.42	1.06	1.17	0.54	0.56
Earnings Per Share
Basic EPS	-3.00	-13.00	-	-86.00	-
Diluted EPS	-3.00	-13.00	-	-86.00	-
Basic Shares Outstanding	5.52	1.55	1.33	0.44	0.00
Diluted Shares Outstanding	5.52	1.55	1.33	0.44	0.00